Gender dysphoria in children and adolescents: an overview

被引:0
作者
Nicos Skordis
Andreas Kyriakou
Shai Dror
Avital Mushailov
Nicolas C. Nicolaides
机构
[1] Paedi Center for Specialized Pediatrics,Division of Pediatric Endocrinology
[2] St George’s,Developmental Endocrinology Research Group
[3] University London Medical Program at the University of Nicosia Medical School,Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics
[4] School of Medicine,Division of Endocrinology and Metabolism, Center of Clinical
[5] University of Glasgow,undefined
[6] National and Kapodistrian University of Athens Medical School,undefined
[7] “Aghia Sophia” Children’s Hospital,undefined
[8] Experimental Surgery and Translational Research,undefined
[9] Biomedical Research Foundation of the Academy of Athens,undefined
来源
Hormones | 2020年 / 19卷
关键词
Gender dysphoria; Adolescents; Genetics; Cross-hormone treatment;
D O I
暂无
中图分类号
学科分类号
摘要
Over the last decade, we have witnessed considerable progress in gender dysphoria (GD) terminology in an attempt to better describe the condition based on certain criteria. The ever-increasing social acceptance and destigmatization of children and adolescents with GD have resulted in an increased number of transgender individuals seeking endocrine care. In addition to terminology and diagnostic criteria, the tremendous progress of genetics and neuroimaging has enabled us to have a deeper understanding of the complex pathogenesis of GD. Although helpful guidelines for treatment with GnRH analogs and gender-affirming hormones have been proposed, several challenges and controversies still exist. In this article, the current knowledge about GD in adolescents is reviewed, with particular emphasis on terminology, clinical manifestations, and epidemiologic data. The neurobiological basis of the condition is presented, and both hormonal treatment and mental issues of transgender individuals are discussed. Undoubtedly, further research will optimize the diagnostic and therapeutic approach of children and adolescents with GD.
引用
收藏
页码:267 / 276
页数:9
相关论文
共 355 条
  • [61] Bertolini I(2016)To treat or not to treat: puberty suppression in childhood-onset gender dysphoria Nat Rev Urol 13 456-1132
  • [62] Clark TC(2016)What the primary care pediatrician needs to know about gender incongruence and gender dysphoria in children and adolescents Pediatr Clin N Am 63 1121-1867
  • [63] Lucassen MFG(2018)Gender dysphoria in adolescence: current perspectives Adolesc Health Med Ther 9 31-e762
  • [64] Bullen P(2018)Ensuring comprehensive care and support for transgender and gender-diverse children and adolescents Pediatrics 142 e20182162-140
  • [65] Denny SJ(2018)Transgender medicine - puberty suppression Rev Endocr Metab Dis 19 221-801
  • [66] Fleming TM(2019)Puberty blocking in gender dysphoria: suitable for all? Arch Dis Child 104 509-69
  • [67] Robinson EM(2016)Efficacy and safety of gonadotropin-releasing hormone agonist treatment to suppress puberty in gender dysphoric adolescents J Sex Med 13 1125-1014
  • [68] Rossen FV(2006)Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty J Clin Endocrinol Metab 91 1862-51
  • [69] Eisenberg ME(2009)Consensus statement on the use of gonadotropin-releasing hormone analogs in children Pediatrics. 123 e752-73
  • [70] Gower AL(2014)Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty Ann Pediatr Endocrinol Metab 19 135-495